Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
immunoxel (1 trial)
v7 (2 trials)
v-5 immunitor (1 trial)
Tuberculosis (Phase 3)
Trials (4 total)
Trial APIs (3 total)